Therapeutic treatment for PTSD using Deep Brain Reorienting
Official title: The Effects of Deep Brain Reorienting (DBR) on Post-traumatic Stress Disorder (PTSD)
Run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · NCT04317820 · Data updated 2026-11-12
This study is testing a new treatment called Deep Brain Reorienting to see if it can help people with PTSD manage their symptoms better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 234 (estimated) |
| Sponsor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Academic / other |
| Locations | 1 site (London, Ontario) |
| Status | Recruiting |
| Started | September 29, 2020 |
| Main results expected | July 2028 |
| Study ends | July 2028 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT04317820 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking adults aged 18-65 who meet the diagnostic criteria for PTSD and may benefit from short-term trauma therapy.
✕Probably not a fit
Patients with significant untreated medical illnesses, neurological disorders, or those currently engaged in extensive counseling therapies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the efficacy of Deep Brain Reorienting (DBR) as a treatment for Post-traumatic Stress Disorder (PTSD). Participants will be randomly assigned to receive either the DBR treatment or be placed on a wait-list. The DBR approach involves processing traumatic memories while focusing on muscle tensions associated with threat orientation, aiming to help participants manage their emotional responses. Assessments will include clinical interviews and fMRI scans conducted both online and in-person to measure changes in PTSD symptoms.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce PTSD symptoms and improve the quality of life for affected individuals.
How similar studies have gone: While the approach of DBR is innovative, similar studies exploring therapeutic techniques for PTSD have shown promise, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * military veteran * English speaking * age: 18-65 * meets diagnostic criteria for PTSD (as determined by study assessment) * may benefit from short-term trauma therapy (as determined by study assessment) Exclusion Criteria: * not a military veteran * Individuals with any implants, conditions, etc. that do not comply with 7-Tesla (7T) fMRI research safety standards (e.g., certain implants, pregnancy) * history of significant head injury/lengthy loss of consciousness (e.g., a Glasgow Coma Scale Score \< 15 at the time of incident assessed retrospectively by participant) * significant untreated medical illness * history of neurological disorder * history of any pervasive developmental disorder * history of bipolar disorder * history of psychotic disorder * alcohol/substance abuse or dependence within the last 3 months * extensive narcotic use * current participation in counselling more extensive than supportive therapy (e.g., exposure therapy, Cognitive-Behavioural Therapy would be an exclusion) * a degree of mental distress that is unlikely to benefit from a short-term therapy (for our participants' well-being, it will be necessary that we believe it possible to safely address the issues/triggers brought up in treatment within the 8 sessions).
Where it's running
-
London Health Sciences Centre - University Hospital
London, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Ruth A Lanius, MD, PhD — London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Study coordinator: Suzy - Study Coordinator
- Email: Suzy.Southwell@lhsc.on.ca
- Phone: 519-685-8500
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Non-invasive vagus nerve stimulation (gammaCore) for PTSD
This study will test whether the handheld gammaCore device, which delivers mild electrical stimulation to the vagus nerve through the neck, can help adults with PTSD reduce their symptoms.
-
Non‑trauma PTSD treatment for veterans and service members with mild or moderate TBI
This pilot will test a non‑trauma psychotherapy program to help veterans and service members with mild or moderate traumatic brain injury who have PTSD.
-
Psilocybin-assisted therapy for PTSD after sexual assault
This trial will test whether a single 25 mg oral dose of psilocybin combined with therapy helps cisgender women who have PTSD from a sexual assault.
-
Short-term therapy for PTSD symptoms
This study is testing a week-long therapy to see if it can help adults with PTSD feel better and reduce their symptoms.
-
Augmented reality-enhanced exposure therapy for PTSD in U.S. military personnel
This tests whether adding augmented reality to standard exposure therapy helps U.S. military veterans and active-duty adults with PTSD.
-
Working memory training to improve fear extinction in veterans with PTSD
This study is testing if a special memory training program can help veterans with PTSD learn to manage their fears better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.